jRCTs051200038已完成不适用
Development of a new cancer diagnostic method based on metabolites derived from samples before and after oral administration of 13C-labeled glucose in patients with PET-positive lung cancer : Single-arm, exploratory clinical trial
未提供0 个研究点目标入组 6 人开始时间: 2020年8月24日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 6
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Diagnostic Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 80age old not（—）
- 性别
- All
入选标准
- •(1) Patients who are at least 20 years old and under 80 years old at the time of obtaining consent
- •(2) PET-positive primary lung cancer patients who can be surgically resected
- •(3) Patients who have given their informed consent to participate in this clinical study
排除标准
- •(1) Patients with other cancers
- •(2) Other patients judged inappropriate by the person in charge of this clinical study
结局指标
主要结局
-
Identification of derived metabolites in blood and urine after 13C glucose administration
次要结局
未报告次要终点
研究者
相似试验
招募中
不适用
Tumormarkers in diagnostics and follow up of lungcarcinomaNL-OMON47860Catharina-ziekenhuis1,500
已完成
Unknown
ongmerkerstudieNL-OMON26180Catharina Ziekenhuis Eindhoven, NWO, Catharina Onderzoeksfonds, Roche Diagnostics Nederland1,500
已完成
不适用
Non-Invasive Biomarkers For Early Detection Of Lung CancersLung CancerNCT01580332Douglas W. Johnson MD, FACR50
招募中
不适用
Lung EpiCheck Biomarkers Development StudyLung CancerNCT06245876Nucleix Ltd.6,000
Unknown
不适用
'Lung Health Check' Biomarker StudyCancerLung CancerNCT04957433Royal Marsden NHS Foundation Trust1,000